eRegister's captcha

Patent Register Details

Print page icon Print this page

PATENT REGISTER
A Supplementary Protection Certificate (SPC) exists for this Patent. To view the SPC Details click following SPC number(s): 2017/035
Status Expired Patent No. 1776957
Application No. 06021697.5 Date of Filing 12/08/1998
Date Grant Published 01/03/2017 Application Published 25/04/2007
Title of Invention USE OF HERPES VECTORS FOR TUMOR THERAPY
Priority
Priority Country Filing Date Application No.
 United States of America  12/08/1997  55142 P
 United States of America  22/04/1998  64174
Inventors Rabkin, Samuel D.
Toda, Masahiroc/o Inst. of Gene and Brain Science
Martuza, Robert L.
Current Proprietor Georgetown University
37th & O Streets, N.W.
Washington, DC 20057
UNITED STATES OF AMERICA
Address for service Anne Ryan & Co
2 Crofton Terrace
Dun Laoghaire
Co. Dublin
A96 V6P7
IRELAND
Renewal Fees
Year Date Renewed
 20  09/08/2017
Earlier Application No. 98939886.2 Revoked by EPO
Publication Language English
Translation Received Date
19/05/2017 Address for Service recorded as Anne Ryan & Co, 2 Crofton Terrace, Dun Laoghaire, Co. Dublin, A96 V6P7, Ireland received on 18/05/2017.
17/08/2017 Request for grant a Supplementary Protection Certificate, citing Patent number 1776957 as the relevant basic patent, in respect of the product Talimogene laherparepvec filed on 15/08/2017. Reference number of request is 2017/035.
03/09/2018 Patent expired on 11/08/2018.
05/05/2021 Request for grant of Supplementary Protection Certification No. 2017/035 rejected in respect of Article 10(2) of Regulation (EC) No. 469/2009